MedTrace Logo

Quantitative Study on HRCT Phenotype of COPD

NCT04953611 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2021-07-08

No results posted yet for this study

Summary

To explore the HRCT phenotype of the combined COPD assessment staging system

Conditions

Sponsors & Collaborators

  • Peking University Third Hospital

    lead OTHER

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-01
Primary Completion
2014-11-30
Completion
2014-11-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04953611 on ClinicalTrials.gov